SCHEMBL30830529

SCHEMBL30830529

CN1C[C@H](Nc2cnn(C)c(=O)c2Cl)C[C@H](c2ccc(CN3CCN(c4cc(C5CCC(=O)NC5=O)c(F)cc4F)CC3)cc2)C1

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 20/20 0.49
▸ BRD9 Q9H8M2 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30831086 0.94 KAT2B (0.41) KAT2BBRD9
SCHEMBL30830894 0.93 KAT2B (0.49) KAT2BBRD9
SCHEMBL30830912 0.91 KAT2B (0.49) KAT2BBRD9
SCHEMBL30830775 0.88 CRBN (0.51) KAT2BBRD9
SCHEMBL30831023 0.87 KAT2B (0.55) KAT2BBRD9
SCHEMBL30830808 0.86 KAT2B (0.47) KAT2BBRD9
SCHEMBL30831090 0.85 KAT2B (0.51) KAT2BBRD9
SCHEMBL30830751 0.85 KAT2B (0.55) KAT2BBRD9
SCHEMBL30830514 0.85 KAT2B (0.41) KAT2BBRD9
SCHEMBL30830813 0.85 KAT2B (0.51) KAT2BBRD9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback